Hematology/Oncology: New Results from Clinical Research Program
2024 10 Jun
Hematology/oncology: AOP Health’s expanding clinical research program delivers new results. AOP Orphan Pharmaceuticals GmbH (AOP Health) continues a successful clinical research program in hematology/oncology with two abstracts accepted for presentation at the European Hematology Association (EHA) 2024 hybrid congress in Madrid, Spain....Read more
Rare Diseases: No Innovative Therapies Without Research
2024 20 Feb
Individualized therapies and the integration of the patient's perspective are becoming increasingly important. February 29 is Rare Disease Day. On this occasion, the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) takes a look at the challenges faced by patients with rare diseases and highlights the trends...Read more
Collaborative Research Ensures Availability of Rare Disease Therapies
2023 14 Nov
To ensure the availability of new therapies for rare diseases, a functioning cooperation between the public sector, academic research and research-based companies is crucial. With this in mind, Vienna's City Councilor for Health, Social Affairs and Sport, Peter Hacker, paid the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH ("AOP Health")...Read more
Inauguration Of Getinge-Supported Research Center In Stockholm
2020 30 Sep
Getinge is one of the industry partners of the new Center for the Advancement of Integrated Medical and Engineering Sciences (AIMES), which today is inaugurated in Stockholm, Sweden. AIMES is the result of a collective effort by the medical research university Karolinska Institutet and KTH Royal Institute of Technology . The center’s...Read more
Philips & the Charité–Universitätsmedizin Berlin Start Joint Research Program
2015 20 Nov
Philips and the Charité – Universitätsmedizin Berlin start joint research program on non-pharmacological methods to prevent delirium in critical care Clinical insights combined with innovative non-pharmacological delirium management solutions may help prevent or lessen delirium and help critical care patients recover faster Royal Philips (NYSE:...Read more
Survey Shows Need for Greater Consistency in “Real World” Observational Research
2015 27 Jul
According to a recent survey, the pharmaceutical, biotech, and medical device industries are aware of the benefits of observational research in better understanding the real world value of their products; however, there is continued need to improve the design and implementation of the studies. Results from the 9th Annual Survey on Observational Research...Read more
